Editors' ChoiceCancer

Epigenetics make transient states of cancer therapy resistance permanent

See allHide authors and affiliations

Science Translational Medicine  28 Jun 2017:
Vol. 9, Issue 396, eaan6729
DOI: 10.1126/scitranslmed.aan6729


Resistance to targeted cancer therapies is mediated by stabilization of transient insensitive states.

View Full Text

Stay Connected to Science Translational Medicine